Literature DB >> 11880389

Evaluation of dry and wet transported intravaginal swabs in detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in female soldiers by PCR.

Charlotte A Gaydos1, Kimberly A Crotchfelt, Nina Shah, Marie Tennant, Thomas C Quinn, Joel C Gaydos, Kelly T McKee, Anne M Rompalo.   

Abstract

Screening women for sexually transmitted diseases (STD) in nonclinic settings is highly desirable because many infections are asymptomatic. This is especially true for military women, for whom logistical, social, and other job-related obstacles present barriers to accessing medical care. We assessed the accuracy of intravaginal swabs transported by mail in a wet versus a dry state for PCR (Amplicor CT/NG test) detection of chlamydia and gonorrhea infections in a cross-sectional study of 793 active-duty military women attending an STD clinic. PCR tests of vaginal swabs (wet and dry) were compared to local clinical methods used on cervical swabs. Standard wet vaginal swab PCR testing detected more chlamydia (11.6%) than cervical enzyme immunoassay (9.3%). For detection of chlamydia using wet swabs, the sensitivity and specificity compared with adjudicated true positives were 94.6% (87 of 92) and 99.3% (696 of 701), respectively. Comparing dry swabs to true-positives for chlamydia, the sensitivity was 91.3% (84 of 92) and the specificity was 99.3% (696 of 701). Standard wet vaginal swab PCR detected more gonorrhea (3.3%) than routine cervical culture (2.1%). The sensitivity and specificity of PCR testing of wet swabs compared to true-positives (infected patients) were 96.3% (26 of 27) and 98.2% (752 of 766) for gonorrhea, respectively. For gonorrhea, the sensitivity and specificity of dry swabs compared to true-positives (infected patients) were 88.9% (24 of 27) and 98.3% (753 of 766), respectively. PCR testing of wet and dry transported intravaginal swabs to detect chlamydia and gonorrhea infections was an accurate diagnostic method for military women.

Entities:  

Mesh:

Year:  2002        PMID: 11880389      PMCID: PMC120245          DOI: 10.1128/JCM.40.3.758-761.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.

Authors:  T Anttila; P Saikku; P Koskela; A Bloigu; J Dillner; I Ikäheimo; E Jellum; M Lehtinen; P Lenner; T Hakulinen; A Närvänen; E Pukkala; S Thoresen; L Youngman; J Paavonen
Journal:  JAMA       Date:  2001-01-03       Impact factor: 56.272

2.  Military women's perspectives on health care during deployment.

Authors:  N A Ryan-Wenger; N K Lowe
Journal:  Womens Health Issues       Date:  2000 Nov-Dec

3.  Trends of gonorrhea and chlamydial infection during 1985-1996 among active-duty soldiers at a United States Army installation.

Authors:  A C Seña; W C Miller; I F Hoffman; H Chakraborty; M S Cohen; P Jenkins; K T McKee
Journal:  Clin Infect Dis       Date:  2000-03-30       Impact factor: 9.079

4.  Diagnosis of Neisseria gonorrhoeae infections in women by using the ligase chain reaction on patient-obtained vaginal swabs.

Authors:  E W Hook; S F Ching; J Stephens; K F Hardy; K R Smith; H H Lee
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

5.  Use of self-collected vaginal specimens for detection of Chlamydia trachomatis infection.

Authors:  M Polaneczky; C Quigley; L Pollock; D Dulko; S S Witkin
Journal:  Obstet Gynecol       Date:  1998-03       Impact factor: 7.661

6.  Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae.

Authors:  D H Martin; C Cammarata; B Van Der Pol; R B Jones; T C Quinn; C A Gaydos; K Crotchfelt; J Schachter; J Moncada; D Jungkind; B Turner; C Peyton
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis.

Authors:  B Van Der Pol; T C Quinn; C A Gaydos; K Crotchfelt; J Schachter; J Moncada; D Jungkind; D H Martin; B Turner; C Peyton; R B Jones
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic.

Authors:  K R Smith; S Ching; H Lee; Y Ohhashi; H Y Hu; H C Fisher; E W Hook
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

9.  Asymptomatic sexually transmitted disease prevalence in four military populations: application of DNA amplification assays for Chlamydia and gonorrhea screening.

Authors:  S K Brodine; M A Shafer; R A Shaffer; C B Boyer; S D Putnam; F S Wignall; R J Thomas; B Bales; J Schachter
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

10.  Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine.

Authors:  H H Lee; M A Chernesky; J Schachter; J D Burczak; W W Andrews; S Muldoon; G Leckie; W E Stamm
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

View more
  23 in total

1.  Current Issues in Screening for Chlamydia trachomatis.

Authors:  Robert L. Cook; Lars ØStergaard
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

2.  Searching for How Best to Accomplish Recommended Rescreening for Genital Chlamydia Infection.

Authors:  Noreen A Hynes
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

Review 3.  Vaginal discharge.

Authors:  Des Spence; Catriona Melville
Journal:  BMJ       Date:  2007-12-01

4.  The laboratory diagnosis of Neisseria gonorrhoeae.

Authors:  Lai-King Ng; Irene E Martin
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

5.  Detection and identification of Mycobacterium species isolates by DNA microarray.

Authors:  Masao Fukushima; Kenichi Kakinuma; Hiroshi Hayashi; Hiroko Nagai; Kunihiko Ito; Ryuji Kawaguchi
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

6.  Stability Studies on Dry Swabs and Wet Mailed Swabs for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Aptima Assays.

Authors:  Jeanne Moncada; Carey B Clark; Jeffrey Holden; Edward W Hook; Charlotte A Gaydos; Julius Schachter
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

7.  Clinical evaluation of the BD ProbeTec™ Neisseria gonorrhoeae Qx amplified DNA assay on the BD Viper™ system with XTR™ technology.

Authors:  Barbara Van Der Pol; Stephanie N Taylor; William Lebar; Thomas Davis; Deanna Fuller; Leandro Mena; Paul Fine; Charlotte A Gaydos; David H Martin; Edward W Hook
Journal:  Sex Transm Dis       Date:  2012-02       Impact factor: 2.830

8.  Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting?

Authors:  Sue Skidmore; Paddy Horner; Alan Herring; Joanne Sell; Ian Paul; Jane Thomas; E Owen Caul; Matthias Egger; Anne McCarthy; Emma Sanford; Chris Salisbury; John Macleod; Jonathan A C Sterne; Nicola Low
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

9.  From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections.

Authors:  Marcia M Hobbs; Barbara van der Pol; Patricia Totten; Charlotte A Gaydos; Anna Wald; Terri Warren; Rachel L Winer; Robert L Cook; Carolyn D Deal; M Elizabeth Rogers; Julius Schachter; King K Holmes; David H Martin
Journal:  Sex Transm Dis       Date:  2008-01       Impact factor: 2.830

10.  Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.

Authors:  Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.